Literature DB >> 24972912

Association between infection of hepatitis B virus and onset risk of B-cell non-Hodgkin's lymphoma: a systematic review and a meta-analysis.

Hai-zhen Yi1, Jin-jing Chen, Hong Cen, Wei Yan, Xiao-hong Tan.   

Abstract

Whether an association between hepatitis B virus (HBV) infection and B-cell non-Hodgkin's lymphoma (B-NHL) risk exists is an open question. In order to provide quantification of the issue, we carried out a meta-analysis of the published data. We identified 4 case-control and 2 nested case-control studies, including a total of 5,396 B-NHL cases. We derived meta-analytic estimates using random-effects models, taking into account the correlation between estimates. The odds radio (OR) of HBV infection in B-NHL when compared with the control population was 2.98 [95 % confidence interval (CI) 2.30-3.86]. There was evidence of statistical heterogeneity among all included studies (I (2) = 65 %, P = 0.01), which disappeared in the subgroup nested case-control studies (I (2) = 0 %, P = 0.49). OR was 2.59 (95 % CI 2.03-3.30) in the random effect model, suggesting a higher prevalence of HBV carrier state in B-NHL than controls. This meta-analysis provides quantitative evidence of a favorable role of HBV infection on B-NHL risk, which needs to be confirmed by experimental and epidemiological studies.

Entities:  

Mesh:

Year:  2014        PMID: 24972912     DOI: 10.1007/s12032-014-0084-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  29 in total

1.  Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Silvia Franceschi; Mauro Lise; Christian Trépo; Pascale Berthillon; Shu-Chun Chuang; Alexandra Nieters; Ruth C Travis; Roel Vermeulen; Kim Overvad; Anne Tjønneland; Anja Olsen; Manuela M Bergmann; Heiner Boeing; Rudolf Kaaks; Nikolaus Becker; Antonia Trichopoulou; Pagona Lagiou; Christina Bamia; Domenico Palli; Sabina Sieri; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Bas Bueno-de-Mesquita; Petra H M Peeters; Laudina Rodríguez; Leila Luján Barroso; Miren Dorronsoro; María-José Sánchez; Carmen Navarro; Aurelio Barricarte; Sara Regnér; Signe Borgquist; Beatrice Melin; Göran Hallmans; Kay-Tee Khaw; Nick Wareham; Sabina Rinaldi; Pierre Hainaut; Elio Riboli; Paolo Vineis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-23       Impact factor: 4.254

Review 2.  The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview.

Authors:  M Luppi; G Torelli
Journal:  Haematologica       Date:  1996 May-Jun       Impact factor: 9.941

3.  Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.

Authors:  M Kuniyoshi; M Nakamuta; H Sakai; M Enjoji; N Kinukawa; K Kotoh; M Fukutomi; M Yokota; H Nishi; H Iwamoto; N Uike; J Nishimura; S Inaba; Y Maeda; H Nawata; K Muta
Journal:  J Gastroenterol Hepatol       Date:  2001-02       Impact factor: 4.029

4.  Quantitative methods in the review of epidemiologic literature.

Authors:  S Greenland
Journal:  Epidemiol Rev       Date:  1987       Impact factor: 6.222

Review 5.  The immune response induced by hepatitis B virus principal antigens.

Authors:  Chien-Fu Huang; Shih-Shen Lin; Yung-Chyuan Ho; Fong-Ling Chen; Chi-Chiang Yang
Journal:  Cell Mol Immunol       Date:  2006-04       Impact factor: 11.530

6.  High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies.

Authors:  Jun Kang; Jeong Hyun Cho; Cheol Won Suh; Dae Ho Lee; Heung Bum Oh; Yong Hak Sohn; Hyun Sook Chi; Chan Jeong Park; Sung Soo Jang; Kyoo Hyung Lee; Je-Hwan Lee; Jung Hee Lee; Sang Wook Lee; Young Hwa Chung; Tae Hyup Kim; Hai-Rim Shin; Jooryung Huh
Journal:  Ann Hematol       Date:  2010-09-07       Impact factor: 3.673

7.  Hematopoietic malignancies associated with viral and alcoholic hepatitis.

Authors:  Lesley A Anderson; Ruth Pfeiffer; Joan L Warren; Ola Landgren; Shahinaz Gadalla; Sonja I Berndt; Winnie Ricker; Ruth Parsons; William Wheeler; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10-28       Impact factor: 4.254

Review 8.  Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.

Authors:  Rohit Loomba; Ayana Rowley; Robert Wesley; T Jake Liang; Jay H Hoofnagle; Frank Pucino; Gyorgy Csako
Journal:  Ann Intern Med       Date:  2008-04-01       Impact factor: 25.391

9.  High incidences of malignant lymphoma in patients infected with hepatitis B or hepatitis C virus.

Authors:  Hiroshi Iwata; Keitaro Matsuo; Kengo Takeuchi; Yukiko Kishi; Naoko Murashige; Masahiro Kami
Journal:  Haematologica       Date:  2004-03       Impact factor: 9.941

10.  The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis.

Authors:  Soon-Thye Lim; Gao Fei; Richard Quek; Lay-Cheng Lim; Lai-Heng Lee; Swee-Peng Yap; Susan Loong; Miriam Tao
Journal:  Eur J Haematol       Date:  2007-08       Impact factor: 2.997

View more
  6 in total

1.  Consecutive stimulation of HBsAg promotes the viability of the human B lymphoblastoid cell line IM-9 through regulating the SIRT1-NF-κB pathway.

Authors:  Jian Bo; Xiaojuan Wang; Jie Li; Wenqing Wang; Jinqian Zhang
Journal:  Oncol Lett       Date:  2017-05-03       Impact factor: 2.967

2.  Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis.

Authors:  Ja Kyung Kim; Soo-Jeong Kim; Yuri Kim; Yong Eun Chung; Young Nyun Park; Hyun Ok Kim; Jin Seok Kim; Mi-Suk Park; Isao Sakaida; Do Young Kim; Jung Il Lee; Sang Hoon Ahn; Kwan Sik Lee; Kwang-Hyub Han
Journal:  Cell Transplant       Date:  2017-01-24       Impact factor: 4.064

3.  High prevalence of hepatitis B virus infection in primary central nervous system lymphoma.

Authors:  Yan Meng; Shengli He; Qin Liu; Dongwen Xu; Tao Zhang; Zi Chen
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.

Authors:  Qiwen Chen; Zhouyu Ning; Lei Wang; Haifeng Ying; Shu Dong; Chenyue Zhang; Xiaoheng Shen; Yuanbiao Guo; Hao Chen; Xiaoyan Zhu; Yehua Shen; Weidong Shi; Yongqiang Hua; Kun Wang; Junhua Lin; Litao Xu; Lianyu Chen; Lanyun Feng; Xiumei Zhang; Jing Xie; Bo Sun; Yaqin Sun; Wenchao Gu; Mei Kang; Zheng Tang; Zhujun Chen; Zhen Chen; Luming Liu; Jinming Yu; Zhaoshen Li; Zhiqiang Meng
Journal:  Oncotarget       Date:  2016-12-20

5.  Establishment and characterization of HBV-associated B lymphocytes with an immortalization potential.

Authors:  Xiaoying Qi; Xien Gui; Ke Zhuang
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

6.  Prognostic impact of hepatitis B virus infection in patients with primary cervical cancer.

Authors:  Xiaoyan Feng; Huaiwu Lu; Yuan Wei; Meimei Guan; Junyi Wang; Changhao Liu; Tianran Shen; Qingsong Chen; Qunxian Rao
Journal:  Cancer Med       Date:  2021-10-21       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.